Pacira BioSciences, Inc.

NASDAQ:PCRX

26.98 (USD) • At close June 4, 2025
Bedrijfsnaam Pacira BioSciences, Inc.
Symbool PCRX
Munteenheid USD
Prijs 26.98
Beurswaarde 1,249,300,806
Dividendpercentage 0%
52-weken bereik 11.16 - 31.13
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. David M. Stack
Website https://www.pacira.com

An error occurred while fetching data.

Over Pacira BioSciences, Inc.

Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses

Vergelijkbare Aandelen

Denali Therapeutics Inc. logo

Denali Therapeutics Inc.

DNLI

14.42 USD

LifeStance Health Group, Inc. logo

LifeStance Health Group, Inc.

LFST

5.95 USD

STAAR Surgical Company logo

STAAR Surgical Company

STAA

16.67 USD

Telesis Bio, Inc. logo

Telesis Bio, Inc.

TBIO

0.285 USD

Roivant Sciences Ltd. logo

Roivant Sciences Ltd.

ROIV

11.21 USD

Neogen Corporation logo

Neogen Corporation

NEOG

4.96 USD

Progyny, Inc. logo

Progyny, Inc.

PGNY

21.3 USD

Privia Health Group, Inc. logo

Privia Health Group, Inc.

PRVA

23.01 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)